Ipsilateral axillary lymphadenopathy after COVID-19 vaccination in a young female; a case report and literature review

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

It has been two years since vaccination for COVID-19 was launched worldwide. In Pakistan, the vaccination started in the beginning of 2020. Since then, several side effects were reported after vaccination, including soreness of the arm, fever, chills, malaise and diarrhoea. Axillary lymphadenopathy has been found to be associated with several conditions that include autoimmune disorders, infections, malignancy and some idiopathic causes. We present a rare case of a 30-y old female with recent recovery from COVID-19, who developed ipsilateral axillary lymphadenopathy after 15 days of Sinovac vaccination. Ultrasonography was done to confirm the diagnosis and its spread towards breast and cervical region. This case report discusses some key points and recommendations regarding unilateral axillary lymphadenopathy after COVID-19 vaccination.

Cite

CITATION STYLE

APA

Butt, M. N., Perveen, W., Malik, S., Raja, S. K., Feroz, R., & Asif, R. (2022). Ipsilateral axillary lymphadenopathy after COVID-19 vaccination in a young female; a case report and literature review. Anaesthesia, Pain and Intensive Care, 26(6), 820–823. https://doi.org/10.35975/apic.v26i6.2066

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free